Use of chick embryo in screening for teratogenicity

A teratology screening system would detect agents hazardous to the conceptus before they can perturb embryonic development in humans. The back log of untested chemicals and the rate at which new substances enter the market exceed the developmental effects testing by standard in vivo method. Thus, cheaper, quicker in vitro systems afford a unique opportunity for investigating the direct interaction of substances with developing morphogenetic system (MGSs), since maternal influences are excluded. As a carrier of a complete set of MGSs, the chick embryo in ovo manifests an advantage over those in vitro systems that employ isolated embryos or embryonic tissues that have only limited survival. Under controlled experimental conditions including standardization of subjects, administration technique and mode of evaluation, according to the basic principles of teratology, the chick embryo test is demonstrated to be reliable and to afford quantifiable end points for evaluation. Individual compounds, mixtures of compounds and against and antagonist can easily be administered and tested. The chick embryo possesses its own basic enzyme-catalyzed drug-transformation capacity and moreover, it can be used for screening specific human metabolites. Different newer techniques e.g. chick embryotoxicity screening test (CHEST), Chick embryo blastoderm model etc are described in detail. Chick embryo fulfills all the criteria which a test should have at a lower level of tier system in teratological studies i.e. modest laboratory equipment, moderate skill, minimal expenditure of time and money, ease of accessibility of embryo, known embryological development, possibility of experimenting on a large scale for statistically valid results and whole animals are also not required.